Before my diagnosis, I never thought about walking. I didn’t think about balance or sensation, or whether my legs would respond when I asked them to move. Walking was automatic until it wasn’t. Autoimmune autonomic ganglionopathy, a rare autoimmune disorder and form of dysautonomia, disrupted my nervous system. It forced me to relearn something I once did without thought: how to move through the world in my own body.
Autoimmune autonomic ganglionopathy affects the autonomic nervous system, which controls functions such as heart rate, blood pressure, and circulation. For me, the disruption quickly became deeply personal. One of the most frightening changes was losing sensation in my legs due to severe neuropathy. I could no longer feel where my legs were or whether my feet touched the ground. Without that sensory connection, walking safely was no longer possible.
As my condition progressed, I began to use a wheelchair. This transition happened quickly and without warning, leaving me totally unprepared for its emotional impact. While the wheelchair allowed me to move safely and maintain some independence, it also dramatically represented how my life had changed in a short period of time. Activities that once required no thought, like leaving the house, attending appointments, and navigating everyday spaces, now required planning, assistance, and adaptation. In addition to learning how to navigate the world differently, I also had to grieve the version of myself who moved freely while learning how to exist in a body that suddenly felt unfamiliar.
A major shift in my experience came when I received a large dose of IVIG, a therapeutic mixture of antibodies collected from healthy blood donors. This treatment, administered intravenously to boost the immune system and treat autoimmune disorders, marked a new chapter. Until that moment, my life was on pause, structured around new limitations and uncertainty.
Following the IVIG infusion, I experienced a new stage of recovery as sensation began to return to my legs. This overwhelming development was not just about the physical experience; it also signified a renewed sense of connection. The contrast between relying on a wheelchair and suddenly feeling the ground beneath my feet was profound. With sensation restored, I was able to walk again.
The shift changed my sense of self almost immediately. Walking again meant trusting my body, something I hadn’t done for months. I could stand without fear, move without constant calculation, and reclaim the autonomy I thought I’d lost.
While I continue to live with autoimmune dysautonomia, that moment reinforced for me how transformative, timely, and appropriate treatment can be—not only physically but also psychologically.
In addition to neurological symptoms, my condition affected my heart. This added unpredictability. Episodes of heart rate and blood pressure instability were frightening reminders that dysautonomia is systemic and far-reaching. Living with cardiac involvement forced me to become deeply attuned to my body. I had to constantly monitor symptoms and learn to respect my limits. It reshaped my understanding of control, vulnerability, and resilience.
IVIG remains a central part of my life. Sitting still for hours, managing side effects, and planning around treatment have become routine. My infusions last up to eight hours, making them both physically and emotionally exhausting. They require endurance, patience, and recovery time. I also see my neurologist frequently, and ongoing monitoring is a constant presence. These experiences are reminders that chronic illness does not pause. It requires continuous adaptation and acceptance.
One of the most profound moments in my journey was experiencing a stroke related to my condition. Recovering from a stroke while already managing dysautonomia showed how fragile normalcy can be. It highlighted how much strength it takes to rebuild after life is disrupted. The stroke forced me to confront vulnerability at a new level. Recovery was emotionally heavy, layered with fear and grief, and filled with uncertainty about what my condition might take next. It changed how I viewed time, health, and stability.
These experiences have fundamentally shaped my desire to work in healthcare. Being a patient taught me lessons no textbook ever could. I learned how deeply it matters when providers listen, believe patients, and respond with urgency and compassion—especially with rare or invisible illnesses. I also learned how damaging dismissal can be. My journey reinforced my commitment to be a healthcare professional who sees the person, not just the diagnosis. I want to understand that healing isn’t always about curing; it’s about restoring trust, dignity, and hope.
Learning to walk again wasn’t just about movement. It was about reclaiming agency, redefining independence, and learning to live in partnership with my body rather than fearing it. Autoimmune autonomic ganglionopathy continues to shape my life, but it does not define it. And my story isn’t about overcoming illness. It’s about adaptation, resilience, and the power of being heard. And if there’s one takeaway, it is this: truly listening to patients can change lives.
Key Takeaways
- An NP student’s experiences reveal how chronic dysautonomia affects her daily life and clinical care.
- IVIG can be a central therapy offering meaningful recovery moments.
- A stroke in addition to dysautonomia complicates rehabilitation and monitoring needs.
- Listening to patients and validating their experiences builds trust and improves care.
- Narrative medicine helps emphasize dignity, agency, and patient voice as being core to care giving.
Try Osmosis from Elsevier today! Access your free trial and find out why millions of current and future clinicians and caregivers love learning by Osmosis.
Leave a Reply